The Greater Cannabis Company, Inc. (GCAND)
OTCMKTS · Delayed Price · Currency is USD
0.1000
-0.2000 (-66.66%)
At close: Oct 17, 2025
The Greater Cannabis Company Employees
The Greater Cannabis Company had 1 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$722,783
Market Cap
90.00K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1 | 0 | - |
| Dec 31, 2023 | 1 | 0 | - |
| Dec 31, 2022 | 1 | 0 | - |
| Dec 31, 2021 | 1 | -1 | -50.00% |
| Dec 31, 2020 | 2 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Federal National Mortgage Association | 8,200 |
| Federal Home Loan Mortgage | 8,103 |
| Central Bancompany | 2,277 |
| Wilson Bank Holding Company | 596 |
| Jingbo Technology | 154 |
| Wilhelmina International | 89 |
The Greater Cannabis Company News
- 3 months ago - GCANRx Announces Uplisting to New Market Tier - GlobeNewsWire
- 10 months ago - GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing - GlobeNewsWire
- 1 year ago - GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy - GlobeNewsWire
- 2 years ago - GCANRx Featured in American Journal of Endocannabinoid Medicine - GlobeNewsWire
- 2 years ago - GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders - GlobeNewsWire
- 3 years ago - GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders - GlobeNewsWire
- 4 years ago - GCANRx Strategic Advisor Dr. Adi Aran to be Interviewed by Dr. Sanjay Gupta on CNN Cannabis Special - GlobeNewsWire
- 4 years ago - GCANRx Appoints Renowned Cannabinoid Researcher Dr. Adi Aran as Strategic Advisor - GlobeNewsWire